How insomnia and depression symptoms are connected in mental health workers during the COVID-19 pandemic
Updated
Abstract
Prevalence rates of insomnia and depression among psychiatric practitioners during the COVID-19 pandemic were 22.2% and 28.5%, respectively.
- Comorbid insomnia and depression affected 16.0% of the sample.
- Network analysis identified 'Distress caused by sleep difficulties' and 'Sleep maintenance' as the most central symptoms.
- 'Motor dysfunction' and 'Sad mood' were also significant central symptoms within the network.
- Key bridge symptoms linking insomnia and depression included 'Sleep dissatisfaction', 'Fatigue', and 'Motor dysfunction'.
- Prioritizing these central and bridge symptoms may assist in developing targeted treatments for this population.
Simplified
Funding
Competing interests
All authors approved the final version for publication. This study was funded by the National Science and Technology Major Project for investigational new drug (2018ZX09201-014), the Beijing Municipal Science & Technology Commission (No. Z181100001518005), the University of Macau (MYRG2019-00066-FHS), Key Medical Discipline of Hangzhou, and The Cultivation Project of the Province-leveled Preponderant Characteristic Discipline of Hangzhou Normal University (18JYXK046, 20JYXK004). The authors report no conflicts of interest.
PubMed